Does the thickness of temporal muscle indicate sarcopenia and functional outcome in older patients with acute stroke?

IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY
Nedim Ongun
{"title":"Does the thickness of temporal muscle indicate sarcopenia and functional outcome in older patients with acute stroke?","authors":"Nedim Ongun","doi":"10.18071/isz.77.0417","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Aging, inactivity, malnutrition and diseases cause sarcopenia and stroke is an important reason of sarcopenia. The aim of this study was to determine the sarcopenia and to evaluate the relationship between functional outcome and temporal muscle thickness using brain CT in older acute stroke patients. </p><p><strong>Methods: </strong>A retrospective study was conducted with acute stroke patients in a single neurology clinic. A total of 114 patients aged 65 years and older were included. Temporal muscle thickness was measured manually using brain computed tomography on admission and third month. Sarcopenia risk and modified Rankin scale scores at 3 months after stroke were assessed. </p><p><strong>Results: </strong>The mean temporal muscle thickness was 5.85±0.96 on admission and 5.67±0.97 on third month in the entire group (p=0.004). Patients with sarcopenia risk score ≥4 on third month, the mean temporal muscle thickness was 5.63±1.02 and 5.32±0.98 on admission and 3rd month respectively (p<0.001). There was a significant correlation between baseline temporal muscle thickness and age (r=-0.728, p<0.001) and body mass index (r= 0.360 , p=0.017). 23 patients (20.1%) had poor functional outcome at 3 months after stroke (mRS>3). A significant correlation was found between temporal muscle thickness on admission and the third month modified Rankin scale score (r=-0.613, p<0.001). </p><p><strong>Conclusion: </strong>Measurement of temporal muscle thickness using brain CT in stroke patients may be a useful method for muscle mass determination and treatment of sarcopenia. </p>","PeriodicalId":50394,"journal":{"name":"Ideggyogyaszati Szemle-Clinical Neuroscience","volume":"77 11-12","pages":"417-421"},"PeriodicalIF":0.9000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ideggyogyaszati Szemle-Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18071/isz.77.0417","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Aging, inactivity, malnutrition and diseases cause sarcopenia and stroke is an important reason of sarcopenia. The aim of this study was to determine the sarcopenia and to evaluate the relationship between functional outcome and temporal muscle thickness using brain CT in older acute stroke patients. 

Methods: A retrospective study was conducted with acute stroke patients in a single neurology clinic. A total of 114 patients aged 65 years and older were included. Temporal muscle thickness was measured manually using brain computed tomography on admission and third month. Sarcopenia risk and modified Rankin scale scores at 3 months after stroke were assessed. 

Results: The mean temporal muscle thickness was 5.85±0.96 on admission and 5.67±0.97 on third month in the entire group (p=0.004). Patients with sarcopenia risk score ≥4 on third month, the mean temporal muscle thickness was 5.63±1.02 and 5.32±0.98 on admission and 3rd month respectively (p<0.001). There was a significant correlation between baseline temporal muscle thickness and age (r=-0.728, p<0.001) and body mass index (r= 0.360 , p=0.017). 23 patients (20.1%) had poor functional outcome at 3 months after stroke (mRS>3). A significant correlation was found between temporal muscle thickness on admission and the third month modified Rankin scale score (r=-0.613, p<0.001). 

Conclusion: Measurement of temporal muscle thickness using brain CT in stroke patients may be a useful method for muscle mass determination and treatment of sarcopenia. 

颞肌厚度是否表明老年急性脑卒中患者肌肉减少和功能结局?
背景与目的:衰老、缺乏运动、营养不良和疾病引起的肌肉减少症和中风是肌肉减少症的重要原因。本研究的目的是利用脑CT确定老年急性脑卒中患者的肌肉减少症,并评估功能结局与颞肌厚度之间的关系。方法:对某神经内科门诊急性脑卒中患者进行回顾性研究。共纳入114例65岁及以上的患者。在入院时和第3个月用脑ct人工测量颞肌厚度。评估脑卒中后3个月肌减少症风险和改良Rankin评分。结果:全组患者入院时平均颞肌厚度为5.85 plusmn;0.96,第3个月时平均颞肌厚度为5.67 plusmn;0.97 (p=0.004)。肌少症风险评分为4分的患者入院第3个月时颞肌平均厚度分别为5.63 plusmn;1.02和5.32 plusmn;0.98 (p < 0.001)。基线颞肌厚度与年龄(r=-0.728, p<0.001)和体重指数(r= 0.360, p=0.017)有显著相关性。23例患者(20.1%)卒中后3个月功能预后较差(mRS>3)。入院时颞肌厚度与第3个月修正Rankin量表评分有显著相关性(r=-0.613, p<0.001)。结论:脑CT测量脑卒中患者颞肌厚度可作为测定肌肉质量和治疗肌少症的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ideggyogyaszati Szemle-Clinical Neuroscience
Ideggyogyaszati Szemle-Clinical Neuroscience CLINICAL NEUROLOGY-NEUROSCIENCES
CiteScore
1.30
自引率
0.00%
发文量
40
审稿时长
>12 weeks
期刊介绍: The aim of Clinical Neuroscience (Ideggyógyászati Szemle) is to provide a forum for the exchange of clinical and scientific information for a multidisciplinary community. The Clinical Neuroscience will be of primary interest to neurologists, neurosurgeons, psychiatrist and clinical specialized psycholigists, neuroradiologists and clinical neurophysiologists, but original works in basic or computer science, epidemiology, pharmacology, etc., relating to the clinical practice with involvement of the central nervous system are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信